Literature DB >> 33670407

Impacts of Drug Interactions on Pharmacokinetics and the Brain Transporters: A Recent Review of Natural Compound-Drug Interactions in Brain Disorders.

Bikram Khadka1, Jae-Young Lee2, Eui Kyun Park3, Ki-Taek Kim1,4, Jong-Sup Bae5.   

Abstract

Natural compounds such as herbal medicines and/or phyto-compounds from foods, have frequently been used to exert synergistic therapeutic effects with anti-brain disorder drugs, supplement the effects of nutrients, and boost the immune system. However, co-administration of natural compounds with the drugs can cause synergistic toxicity or impeditive drug interactions due to changes in pharmacokinetic properties (e.g., absorption, metabolism, and excretion) and various drug transporters, particularly brain transporters. In this review, natural compound-drug interactions (NDIs), which can occur during the treatment of brain disorders, are emphasized from the perspective of pharmacokinetics and cellular transport. In addition, the challenges emanating from NDIs and recent approaches are discussed.

Entities:  

Keywords:  blood–brain barrier (BBB) and blood–cerebrospinal fluid barrier (BCSFB); brain disorders; drug transporters; natural compound–drug interactions (NDIs); pharmacokinetics

Mesh:

Substances:

Year:  2021        PMID: 33670407      PMCID: PMC7917745          DOI: 10.3390/ijms22041809

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  107 in total

Review 1.  Complex interactions between phytochemicals. The multi-target therapeutic concept of phytotherapy.

Authors:  Thomas Efferth; Egon Koch
Journal:  Curr Drug Targets       Date:  2011-01       Impact factor: 3.465

Review 2.  Herb-Drug Interactions of Commonly Used Chinese Medicinal Herbs.

Authors:  Amrinder Singh; Kaicun Zhao
Journal:  Int Rev Neurobiol       Date:  2017-04-14       Impact factor: 3.230

3.  Effects of sinapic acid on hepatic cytochrome P450 3A2, 2C11, and intestinal P-glycoprotein on the pharmacokinetics of oral carbamazepine in rats: Potential food/herb-drug interaction.

Authors:  Mohammad Raish; Ajaz Ahmad; Mushtaq Ahmad Ansari; Khalid M Alkharfy; Abdul Ahad; Fahad I Al-Jenoobi; Abdullah M Al-Mohizea; Altaf Khan; Naushad Ali
Journal:  Epilepsy Res       Date:  2019-03-22       Impact factor: 3.045

4.  Pharmacokinetic and pharmacodynamic interactions of valproate, phenytoin, phenobarbitone and carbamazepine with curcumin in experimental models of epilepsy in rats.

Authors:  K H Reeta; Jogender Mehla; Monika Pahuja; Yogendra Kumar Gupta
Journal:  Pharmacol Biochem Behav       Date:  2011-05-30       Impact factor: 3.533

5.  Effects of garlic (Allium sativum L.) supplementation on cytochrome P450 2D6 and 3A4 activity in healthy volunteers.

Authors:  John S Markowitz; C Lindsay Devane; Kenneth D Chavin; Robin M Taylor; Ying Ruan; Jennifer L Donovan
Journal:  Clin Pharmacol Ther       Date:  2003-08       Impact factor: 6.875

Review 6.  Brain barriers: Crosstalk between complex tight junctions and adherens junctions.

Authors:  Silvia Tietz; Britta Engelhardt
Journal:  J Cell Biol       Date:  2015-05-25       Impact factor: 10.539

Review 7.  Age-Associated Changes in the Immune System and Blood⁻Brain Barrier Functions.

Authors:  Michelle A Erickson; William A Banks
Journal:  Int J Mol Sci       Date:  2019-04-02       Impact factor: 5.923

8.  No Clinically Relevant Interactions of St. John's Wort Extract Ze 117 Low in Hyperforin With Cytochrome P450 Enzymes and P-glycoprotein.

Authors:  Catherine Zahner; Esther Kruttschnitt; Julia Uricher; Michael Lissy; Martin Hirsch; Simon Nicolussi; Stephan Krähenbühl; Jürgen Drewe
Journal:  Clin Pharmacol Ther       Date:  2019-03-23       Impact factor: 6.875

9.  Brain-targeted intranasal delivery of dopamine with borneol and lactoferrin co-modified nanoparticles for treating Parkinson's disease.

Authors:  Shengnan Tang; Aiping Wang; Xiuju Yan; Liuxiang Chu; Xiucheng Yang; Yina Song; Kaoxiang Sun; Xin Yu; Rongxia Liu; Zimei Wu; Peng Xue
Journal:  Drug Deliv       Date:  2019-12       Impact factor: 6.419

10.  A comprehensive review of the therapeutic and pharmacological effects of ginseng and ginsenosides in central nervous system.

Authors:  Hee Jin Kim; Pitna Kim; Chan Young Shin
Journal:  J Ginseng Res       Date:  2013-03       Impact factor: 6.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.